MedPath

Analysis of immune status of the tumor microenvironment in esophageal cancer patients treated with PD-1 blockade therapy

Not Applicable
Recruiting
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000043113
Lead Sponsor
Chiba Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Clinicians judge as ineligible cases.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association between efficacy of PD-1 blockade therapy and immune profiling
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath